Immune Response extends expiry on warrants issued in March placement

By Sheri Kasprzak

New York, Nov. 8 - Immune Response Corp. has extended the expiration date on second tranche warrants issued in a March private placement of convertible notes.

The warrants - for 600 million shares - will now expire March 1, 2007, pushed back from Nov. 30, 2006.

The warrants remain exercisable at $0.02 each.

The warrants were issued March 7, 2006 when the company sold $8 million in convertible notes. The notes, due Jan. 1, 2008, are convertible at $0.02 each.

Based in Carlsbad, Calif., Immune Response is a biopharmaceutical company focused on immune-based therapies for HIV and multiple sclerosis.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.